# VNDA — Vanda Pharmaceuticals Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** VNDA  
**Sources:** 22  
**Published:** 2026-10-31  
**Canonical:** https://app.k3vl4r.com/research/deep-research-vnda-vanda-pharmaceuticals-inc-catalysts-narrative-risks-10383

---

# Vanda Pharmaceuticals Inc. (VNDA) — Research Summary as of 2026-10-31

*Note on source reliability: Several sources below are flagged in their original form as AI-generated or as proprietary "calibrated estimates" and are subject to error ([[3]](https://www.marketbeat.com/earnings/reports/2026-10-28-vanda-pharmaceuticals-inc-stock/), [[1]](https://catalystalert.io/research/VNDA)). Figures that corroborate across independent outlets (SEC-derived data, MarketBeat, Yahoo Finance, PRNewswire) are treated as higher-confidence. I do not verify, re-derive, or report back the earlier point-in-time snapshot data (e.g., the ~$229.18M market cap noted for 2026-10-30), which was provided as background only.*

## Recent Catalysts (roughly July–October 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-vnda-vanda-pharmaceuticals-inc-catalysts-narrative-risks-10383 (free to sign up)._